Difference between revisions of "CD166 antigen/Activated leukocyte cell adhesion molecule"
(Created page with "{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" ! {{infobox header}}| '''{{PAGENAME}}''' |- | Substrate pepti...") |
m |
||
| Line 3: | Line 3: | ||
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
| − | | | + | | Activated leukocyte cell adhesion molecule |
|- | |- | ||
| Synonyms | | Synonyms | ||
| − | | | + | | CD166 antigen |
|- | |- | ||
| Determination type | | Determination type | ||
Revision as of 12:46, 13 January 2012
| Template:Infobox header| CD166 antigen/Activated leukocyte cell adhesion molecule | |
|---|---|
| Substrate peptide name | Activated leukocyte cell adhesion molecule |
| Synonyms | CD166 antigen |
| Determination type | In situ |
| Source | Homo sapiens |
| Subcellular localization | Cytosol |
| Swissprot ID | Q13740 |
| Interacting residues | |
| Interacting sequence | |
| TG2 Swissprot ID | P21980 |
| Interacting residues of TG2 | |
| Interacting sequence of TG2 | |
| Structure | 1KJC |
| Surface accessibility | |
| Disorder prediction | IUPred |
| Reference | PMID:21960143 |
| Notes | In a binding experiment it was identified as a protein which binds TG2. |
| Template:Infobox header | |
